Trial intelligence / Profile preview

Inspiratory Flow of Placebo Tiotropium Easyhaler vs HandiHaler in COPD and Healthy Volunteers

NCT04147572Completed

Sponsor
Orion Corporation
Start
Nov 2019
Primary completion
Jan 2020
Countries
1
01

Overview

Randomised, open-label trial (5 arms), sponsored by Orion Corporation. Primary endpoint: Peak Inspiratory Flow rate at 1 day. Started Nov 2019; status: completed.

Beyond the preview

Go deeper on NCT04147572.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04147572.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call